| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 267,604 | 168,956 | 102,472 | | Cost of Revenue | 64,139 | 47,686 | 22,608 | | | Gross Profit | 203,465 | 121,270 | 79,864 | | | Operating Expenses | | Research Development | 40,189 | 30,000 | 18,320 | | Selling General and Administrative | 124,936 | 95,801 | 54,021 | | Non Recurring |
-
|
-
|
-
| | Others | 1,962 | 811 | 155 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 36,378 | (5,342) | 7,368 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 950 | 2,812 | 3,983 | | Earnings Before Interest And Taxes | 37,328 | (2,530) | 11,351 | | Interest Expense | 6,287 | 4,019 | 85 | | Income Before Tax | 31,041 | (6,549) | 11,266 | | Income Tax Expense | 10,993 | (4,461) | 3,598 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 20,048 | (2,088) | 7,668 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| 69 | | Other Items |
-
|
-
|
-
| | | | Net Income | 20,048 | (2,088) | 7,737 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $20,048 | ($2,088) | $7,737 |
|
1.48% Nasdaq 
Income Statement
